Drugs
TORONTO, ON: TORONTO, ON -- (Marketwired) -- 01/12/15 -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces due diligence update with the disclosure of total number of plants, strains and current dispensaries ...
SOUTH SAN FRANCISCO, CA: California Statesman Brings More Than 50 Years of Broad-Ranging Experience to Support Development of Groundbreaking Treatment for Sickle Cell Disease ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 01/07/15 -- Canadian Cannabis Corp. ("CCAN" or "The Company") (OTCQB: CCAN), is pleased to announce that it has entered into a Letter of Inte ...
LOUISVILLE, CO: AB101 Positioned to Be the First Once-Weekly Basal Insulin for Diabetes Patients ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 01/06/15 -- (OTCBB: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing i ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwired) -- 01/06/15 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reconfirmed its anticipated year-end 2014 revenue and non-GAAP earnings per share (EPS) guidance, a ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 01/05/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today, through its U.S. opera ...
PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 01/05/15 -- Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 01/05/15 -- Global Blood Therapeutics (GBT), a biopharmaceutical company developing novel small molecule therapeutics for the treatment of severe blood dis ...
BEVERLY, MA: BEVERLY, MA -- (Marketwired) -- 01/05/15 -- Cellceutix Corporation (OTCQB: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology, d ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 01/01/15 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"), a leading Canadian specialty pharmaceutical company, today annou ...
SAN FRANCISCO, CA and YAVNE, ISRAEL: SAN FRANCISCO, CA and YAVNE, ISRAEL -- (Marketwired) -- 12/22/14 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it has exercised its option under the terms of the license agreement announced ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 12/18/14 -- Merus Labs International Inc. ("Merus" or the "Company") (TSX: MSL)(NASDAQ: MSLI) is pleased to announce today its financial resu ...
BOTHELL, WA and SAN DIEGO, CA: MiNA Therapeutics to Develop Therapeutics Utilizing Proprietary saRNA Compounds Combined With Marina's Novel SMARTICLES(R) Delivery Technology ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 12/16/14 -- Flamel Technologies (NASDAQ: FLML) announced today that it is moving all intangible property from its French entity to its Irish-based entity as a part of ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/16/14 -- VANC Pharmaceuticals Inc. ("Vanc" or the "Company") (TSX VENTURE: NPH)(OTCQB: NUVPF) is pleased to announce that it ha ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 12/16/14 -- Knight Therapeutics Inc. (TSX: GUD), through one of its wholly owned subsidiaries ("Knight"), announced today that it has committed to inve ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 12/15/14 -- The Board of Directors of Merus Labs International Inc. ("Merus" or the "Company") (TSX: MSL)(NASDAQ: MSLI) is pleased to announc ...
NEW YORK, NY: KD025 Among Therapeutic Candidates Representing the Future of Lupus Treatment ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/10/14 -- VANC Pharmaceuticals Inc. (TSX VENTURE: NPH)(OTCQB: NUVPF) ("VANC" or the "Company"), a pharmaceutical company focused ...
